PLOD1 and obesity disorder: Furthermore, the endocrine and metabolic effects of KD are primarily characterized by a considerable decline in fasting serum insulin, percentage of free testosterone, weight, and luteinizing hormone (LH)/follicle-stimulating hormone (FSH) ratio in females with PCOS and obesity (10).